V. Tritto

发表

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients

P. Zuccotti, M. Eoli, D. Bianchessi, 2019, Genes.

A Translational Approach to Spinal Neurofibromatosis: Clinical and Molecular Insights from a Wide Italian Cohort

C. Santoro, M. Eoli, C. Cesaretti, 2022, Cancers.

Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes

M. Eoli, P. Riva, M. Moscatelli, 2022, International journal of molecular sciences.

Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes

P. Riva, D. Capitanio, V. Tritto, 2023, International journal of molecular sciences.

Preclinical and clinical evidence on the approach-avoidance conflict evaluation as an integrative tool for psychopathology

M. Bellani, M. G. Rossetti, E. Battaglioli, 2022, Epidemiology and psychiatric sciences.

Deregulated expression of polycomb repressive complex 2 target genes in a NF1 patient with microdeletion generating the RNF135-SUZ12 chimeric gene

D. Milani, P. Riva, Federico Grilli, 2023, neurogenetics.

EC NEUROLOGY Opinion NF1 Gene Mutation Mediates Neuronal Signaling De-Regulation Triggering Pediatric Optic Glioma Development: Another Small Step towards a Cure of NF1 Disorder?

P. Riva, Viviana Tritto, V. Tritto, 2021 .

New insights into the molecular basis of spinal neurofibromatosis type 1

M. Eoli, C. Cesaretti, F. Natacci, 2023, European Journal of Human Genetics.

Expression analysis of NF1-mutated alleles in a rare compound heterozygous spinal NF1 patient by digital PCR.

M. Eoli, R. Paterra, P. Bettinaglio, 2023, Annals of human genetics.

Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes

M. Eoli, C. Cesaretti, F. Natacci, 2024, Human genetics.